Lobbying Relationship

Client

EMERGENT BIOSOLUTIONS, INC. (formerly BioPort Corporation)

More records

Lobbying firm

DALRYMPLE & ASSOCIATES, LLC

More records

  • Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion (RSDL).
  • Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,

Duration: to

General Issues: Defense, Homeland Security, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues

Spending: about $1,521,000 (But it's complicated. Here's why.)

Agencies lobbied since 2007: U.S. Senate, House of Representatives, Air Force - Dept of, Army - Dept of (Other), Defense - Dept of (DOD), Centers For Disease Control & Prevention (CDC), Defense Logistics Agency, Defense Threat Reduction Agency (DTRA), Joint Chiefs of Staff, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS), Natl Institutes of Health (NIH), White House Office, Defense Advanced Research Projects Agency (DARPA), Defense - Dept of (DOD), Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS), Army - Dept of (Other) , Ballistic Missle Defense Organization, Health Resources & Services Administration (HRSA), Y Y Department of Defense, Department of Health and Human Services, Department of Homeland Security, Y Y Department of Health and Human Services, CDC, NIAID, FDA, White House, Department of Defense

Bills mentioned

H.R.1300: First Responder Anthrax Preparedness Act

Sponsor: Peter T. King (R-N.Y.)

S.1915: First Responder Anthrax Preparedness Act

Sponsor: Kelly Ayotte (R-N.H.)

H.R.3299: Strengthening Public Health Emergency Response Act of 2016

Sponsor: Susan Brooks (R-Ind.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Donald "Dack" Dalrymple Principal
Donald "Dack" W. Dalrymple Principal
Donald Dalrymple n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q4 Report
Q3 Report
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
MM Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page